THE POSPONT RESULTS OF SWITCHING ON TOPIRAMAT GENERICS AT PATIENTS WITH EPILEPSY
Abstract: long-term results are presented for a switch from the brand formulation to generic topiramate preparations in adult patients suffering from symptomatic or cryptogenic focal epilepsy. A total of 110 study subjects (49 men and 61 women aged from 21 to 70 years) and 22 reference controls were...
Main Author: | I. G. Rudakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2016-05-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/104 |
Similar Items
-
Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision
by: Irina Gennadyevna Rudakova, et al.
Published: (2015-10-01) -
Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
by: Bosak M, et al.
Published: (2017-08-01) -
THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
by: K. Yu. Mukhin, et al.
Published: (2016-08-01) -
RATIONAL APPROACH TO A COMBINATION THERAPY OF FOCAL EPILEPSY
by: I. G. Rudakova
Published: (2016-05-01) -
Analysis of patients’ request to switch from a generic drug to the original drug in external prescriptions
by: Yuhei Hamada, et al.
Published: (2020-12-01)